SAN JUAN CAPISTRANO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of the following skilled nursing facilities in Tennessee and Alabama:
As previously reported, six of these operations are jointly owned by CareTrust REIT, Inc. (NYSE: CTRE, “CareTrust”) and a joint venture investor and are subject to a new, long-term triple net master lease with Ensign affiliated operating companies effective January 1, 2025. The remaining three operations were purchased by Standard Bearer Healthcare REIT, Inc., Ensign’s captive real estate subsidiary effective December 31, 2024. All nine operations are operated by Ensign affiliated operating companies.
Barry Port, Ensign’s Chief Executive officer commented, “We couldn’t be happier to see this deal completed. This acquisition provided an extraordinary opportunity for us to grow our presence in Tennessee and start a new footprint in Alabama. Our local leadership team has been working nonstop to prepare for this acquisition and I am thrilled to see their hard work pay off. We expect that these operations will become significant contributors to the success of their clusters and our organization as a whole.”
Tyler Albrechtsen, Director of Rocky Top Healthcare LLC, and Southstone Healthcare LLC, Ensign’s Tennessee and Alabama based subsidiaries added, “We are so excited to add these operations and the local caregivers to our team. We have been incredibly impressed with everyone we have met and are looking forward to serving the residents and families at these amazing facilities.”
Ensign’s growing portfolio consists of 333 healthcare operations, 30 of which also include senior living operations, across 15 states. Ensign subsidiaries, including Standard Bearer, own 129 real estate assets, 96 of which it operates. Mr. Port reaffirmed that the organization is actively seeking several other transactions to acquire real estate and to lease both well-performing and struggling skilled nursing, senior living and other healthcare related businesses throughout the United States.
About Ensign(TM)
The Ensign Group, Inc.'s independent subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 333 healthcare facilities in Alabama, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. As part of its investment strategy, the Company will also acquire, lease and own healthcare real estate to service the post-acute care continuum through acquisition and investment opportunities in healthcare properties. Ensign’s new business venture operating subsidiaries also offer several other post-acute-related services, including mobile x-ray, emergency and non-emergency transportation services, long-term care pharmacy and other consulting services also across several states. More information about Ensign is available at http://www.ensigngroup.net.
About CareTrust
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States. More information about CareTrust REIT is available at www.caretrustreit.com.
Contact Information
The Ensign Group, Inc., (949) 487-9500, This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$136.81 |
Daily Change: | -2.52 -1.81 |
Daily Volume: | 180,746 |
Market Cap: | US$7.840B |
December 18, 2024 November 13, 2024 November 04, 2024 October 29, 2024 October 24, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load